New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
09:06 EDTAVNRAvanir's migraine candidate New Drug Application accepted by FDA
Avanir Pharmaceuticals' New Drug Application of AVP-825, its investigational drug-device combination product for the acute treatment of migraine, has been accepted by the FDA. The Prescription Drug User Fee Act V goal date is November 26.
News For AVNR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
16:57 EDTAVNRAvanir receives CRL from FDA on AVP-825
Subscribe for More Information
07:48 EDTAVNRFDA PDUFA Date for Avanir's AVP-825 is November 26, 2014
Subscribe for More Information
November 24, 2014
10:32 EDTAVNRDoctors viewing Avanir AVP-923 data favorably, says Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use